Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection
Gupta Charu N.,
Khan Zeba M.,
Chandra Amitabh and
Philipson Tomas J.
Additional contact information
Gupta Charu N.: The Wharton School of the University of Pennsylvania – Health Care Management Department, PA, USA
Khan Zeba M.: Celgene Corporation, Summit, New Jersey, USA
Chandra Amitabh: Harvard University – John F. Kennedy School of Government, Boston, MA, USA
Philipson Tomas J.: University of Chicago – Irving B. Harris Graduate School of Policy Studies, Chicago, IL, USA
Forum for Health Economics & Policy, 2016, vol. 19, issue 1, 141-156
Introduction: There have been significant improvements in both treatment and screening efforts for many types of cancer over the past decade. However, the effect of these advancements on the survival of cancer patients is unknown, and many question the value of both new treatments and screening efforts.
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
https://www.degruyter.com/view/j/fhep.2016.19.issu ... -0028.xml?format=INT (text/html)
For access to full text, subscription to the journal or payment for the individual article is required.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:bpj:fhecpo:v:19:y:2016:i:1:p:141-156:n:6
Ordering information: This journal article can be ordered from
Access Statistics for this article
Forum for Health Economics & Policy is currently edited by Dana Goldman
More articles in Forum for Health Economics & Policy from De Gruyter
Bibliographic data for series maintained by Peter Golla ().